Skip to main content
. 2007 Oct 3;3(2):129–134. doi: 10.1007/s11552-007-9079-6

Table 1.

sICAM-1 and sTM levels (control vs. vibration).

Patient sICAM-1 (Reference: 132.5–344.1 ng/ml) sTM (Reference: 3.01–4.11 ng/ml) Stockholm Workshop Scale
Control 1 209.7 2.27 SN0 V0
Control 2 185.2 3.04 SN0 V0
Control 3 285.5 2.32 SN0 V0
Control 4 151.0 2.57 SN0 V0
Control 5 197.1 2.95 SN0 V0
Control 6 214.2 2.88 SN0 V0
Control 7 321.8 2.49 SN0 V0
Control 8 278.3 3.40 SN0 V0
Control 9 217.6 3.54 SN0 V0
Control 10 163.9 3.17 SN0 V0
Control 11 182.5 3.57 SN0 V0
Vibration 1 310.6 3.36 SN1 V1
Vibration 2 242.0 3.70 SN1 V1
Vibration 3 240.5 3.53 SN1 V1
Vibration 4 245.2 3.73 SN1 V1
Vibration 5 267.7 3.91 SN1 V1
Vibration 6 306.0 3.19 SN1 V1
Vibration 7 310.8 3.69 SN1 V1
Vibration 8 385.2 3.66 SN1 V2
Vibration 9 267.6 3.30 SN1 V2
Vibration 10 346.4 3.97 SN1 V2
Vibration 11 381.4 3.65 SN1 V2

Stockholm Workshop Scale (SN = sensorineural, V = vascular). SN0, no symptoms; SN1, intermittent numbness or tingling; SN2, intermittent or persistent numbness, reduced sensory perception; SN3, intermittent or persistent numbness, reduced tactile discrimination; V0, no attacks; V1, occasional attacks affecting only finger tips; V2, occasional attacks affecting distal/middle phalanges; V3, frequent attacks affecting all phalanges; V4, stage 3 with skin changes in finger tips